Alterations of the TP53 gene were detected in 64 (20.8%) tumors (Table A6, see Additional file1); a high number of TP53 mutated samples were found in colorectal cancer (19/31; 61.3%) and in glioma (25/97; 25.8%). This evidence concerns the gene TP53 and colorectal cancer.